Navigation Links
Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development

PRINCETON, N.J., Sept. 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Steven R. Johnson as Vice President, Business Development. Mr. Johnson will be responsible for Laureate's worldwide business development activities, including sales, marketing, business development and project management, supporting the company's contract development, protein manufacturing, testing and aseptic filling businesses.

"Steve brings a proven track record of sales management in the biologics market combined with extensive senior relationships," said Michael A. Griffith, Chief Executive Officer of Laureate Pharma.  "He is an industry leader and brings to Laureate Pharma an impressive background that includes broad international business development experience in contract manufacturing of monoclonal antibodies, biopharmaceuticals and chemical active pharmaceutical ingredients."

"Steve is a great fit at Laureate and is well-positioned to take us to the next level with our clients as we prepare to invest in growth of the business," said Mr. Griffith who recently joined Laureate Pharma as Chief Executive Officer and is also a member of the Board of Directors. He was the Founder and Chief Executive Officer of Aptuit, Inc., and the Chairman and Chief Executive Officer of ChiRex, Inc.

Mr. Johnson joins Laureate from Lonza where he served most recently as Vice President Global Business Development, and previously as Vice President, Sales and Business Development, North America. In both positions, Steve supported several of Lonza's contract manufacturing business units, including cell culture protein manufacturing, microbial protein production and stem cell production. Previously, Steve held the position of Vice President, Sales North America for Degussa Fine Chemicals. He began his career as a microbiologist in Merck's Chemical Manufacturing Division and transitioned to roles of increasing responsibility in purchasing, sourcing and business development. Steve earned a B.S. in Microbiology from the University of Illinois and an MBA from James Madison University.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ.  With more than 30 years of experience, Laureate provides the range of services required for the manufacture of monoclonal antibodies and other biopharmaceutical products produced by mammalian cells including cell line development, media optimization, process development, formulation, pilot production, cGMP production for clinical and commercial supply, aseptic fill/finish, and assistance with regulatory support and CMC documentation. Laureate is a portfolio company of Saints Capital, LLC.

About Saints Capital, LLC.

Saints Capital is a leading direct secondary acquirer of venture capital and private equity investments in emerging growth companies around the globe. It also makes traditional direct venture capital investments on a primary basis and in special situations in technology, healthcare, consumer and industrial companies in the United States. Founded in 2000, Saints provides liquidity for private investors in such markets as investment and commercial banks, buyouts, corporate venture capital and hedge funds. Saints has more than $1 billion of committed capital under management, over 50 completed portfolio transactions and investments in more than 200 companies. For more information, please visit

SOURCE Laureate Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
3. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
4. Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
5. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
6. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
7. Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
9. New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format
10. China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores
11. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):